RxSight, Inc. Hits 52-Week Low of $4.58 Amidst 92.2% Decline

RxSight, Inc., a microcap company in the Electronics & Appliances industry, has reached a new 52-week low of USD 4.58 as of June 10, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 92.2% over the past year, starkly contrasting with the S&P 500's performance of 20.34% during the same period. The company's financial metrics indicate ongoing difficulties, with a negative return on equity of -14.13% and a debt-to-equity ratio of -0.82. Additionally, RxSight has reported negative results for the last four consecutive quarters, culminating in a notable drop in net sales of 18.48%. The inventory turnover ratio stands at a low of 1 time, while the debtors turnover ratio is also at a concerning 4.77 times. With a market capitalization of USD 258 million, RxSight's stock has underperformed significantly, generating a return of -67.91% over the past year. The stock's 52-week high was recorded at USD 15.81, highlighting the stark contrast to its current position.